Development and validation of a nomogram to predict diabetes ketoacidosis resolution time in a tertiary care hospital in the United Arab Emirates [0.03%]
在阿拉伯联合酋长国一家三级护理医院开发和验证预测糖尿病酮症酸中毒缓解时间的列线图模型的研究
Raya Almazrouei,Amatur Rahman Siddiqua,AbdulRhman Alanqar et al.
Raya Almazrouei et al.
Aim: This study aimed to develop and validate a nomogram to predict prolonged diabetes ketoacidosis (DKA) resolution time (DRT). Methods: ...
Can the postload-fasting glucose gap be used to determine risk of developing diabetes in chinese adults: A prospective cohort study [0.03%]
空腹与餐后血糖差值能否用于判断中国成年人糖尿病发病风险的一项前瞻性队列研究
Xiaohan Xu,Duolao Wang,Shabbar Jaffar et al.
Xiaohan Xu et al.
Objective: To evaluate the relationship between fasting plasma glucose (FPG) and 2-hour postload plasma glucose (2hPG) measured during an oral glucose tolerance test, and the risk of developing diabetes in Chinese adults....
Diabetic peripheral neuropathy and glycemic variability assessed by continuous glucose monitoring: A systematic review and meta-analysis [0.03%]
连续血糖监测评估的糖尿病外周神经病和血糖变异性：系统评价和-meta-分析
Yifan Jia,Dan Long,Yunshuang Yang et al.
Yifan Jia et al.
Continuous glucose monitoring (CGM)-derived metrics have been used to accurately assess glycemic variability (GV) to facilitate management of diabetes mellitus, yet their relationship with diabetic peripheral neuropathy (DPN) is not fully u...
Impact of hospital-community diabetes management intervention in Central Region, Ghana: A retrospective study [0.03%]
加纳中部地区医院社区糖尿病管理干预回顾性研究的影响分析
Julius Waamsasiko Adong,David Nana Adjei,Martin Nyaaba Adokiya et al.
Julius Waamsasiko Adong et al.
Objective: Effective diabetes management remains suboptimal in low-resourced countries including Ghana. We determined the effectiveness of hospital-community link diabetes management intervention on glycaemic control and ...
Corrigendum to "The association between changes in hepatic steatosis and hepatic fibrosis with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: A nationwide cohort study" [Diabetes Res. Clin. Pract. 194 (2022) 110191] [0.03%]
糖尿病前期肝脂肪变性与肝脏纤维化变化对心血管结局和死亡率的影响：一项全国队列研究的更正说明
Jiyun Park,Gyuri Kim,Bong-Sung Kim et al.
Jiyun Park et al.
Prediction of the 10-year incidence of type 2 diabetes mellitus based on advanced anthropometric indices using machine learning methods in the Iranian population [0.03%]
基于机器学习方法利用高级人体测量指标预测伊朗人群2型糖尿病的10年发病率
Somayeh Ghiasi Hafezi,Maryam Saberi-Karimian,Morteza Ghasemi et al.
Somayeh Ghiasi Hafezi et al.
Background: Type 2 diabetes mellitus (T2DM) is a growing chronic disease that can lead to disability and early death. This study aimed to establish a predictive model for the 10-year incidence of T2DM based on novel anthr...
Age of type 2 diabetes onset as a risk factor for dementia: A 13-year retrospective cohort study [0.03%]
糖尿病发病年龄与痴呆之间的关系：一项13年的回顾性队列研究
Rossella Messina,Briana Mezuk,Simona Rosa et al.
Rossella Messina et al.
Aims: To examine whether age at type 2 diabetes onset is an independent predictor of dementia risk. Methods: Retrospective cohort drawn...
Lower achievement of guideline recommended care in Canadian adults with early-onset diabetes: A population-based cohort study [0.03%]
加拿大成人早期发病糖尿病患者指南推荐治疗效果较差：基于人口的队列研究
Apishanthi Sriskandarajah,Amy Metcalfe,Kara A Nerenberg et al.
Apishanthi Sriskandarajah et al.
Aims: Adults with early-onset diabetes (age < 40 years) have an increased risk of complications, and it is unclear whether they are receiving guideline recommended care. We compared the frequency and results of haemoglobi...
Tirzepatide use and the risk of cancer among individuals with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials [0.03%]
司美格鲁肽的使用与2型糖尿病患者癌症风险的关系：随机对照试验的meta分析研究
Djordje S Popovic,Dimitrios Patoulias,Lazar S Popovic et al.
Djordje S Popovic et al.
Background: Tirzepatide has recently been approved for the treatment of type 2 diabetes mellitus (T2DM), based on its impressive effects on glycemia and body weight reduction. We investigated whether tirzepatide affects t...
Tirzepatide 5, 10 and 15 mg versus injectable semaglutide 0.5 mg for the treatment of type 2 diabetes: An adjusted indirect treatment comparison [0.03%]
特立帕肽5、10和15毫克与司美格鲁肽0.5毫克注射液治疗2型糖尿病的疗效比较：一种调整后的间接治疗对比方法
Hamza Zaheer,Muhammad Hammad Zaheer
Hamza Zaheer